Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

Exagen Inc. (XGN) Misses Q4 EPS by 6c, Revenue Beats, Offers Guidance

March 20, 2023 4:08 PM EDT

Exagen Inc. (NASDAQ: XGN) reported Q4 EPS of ($0.83), $0.06 worse than the analyst estimate of ($0.77). Revenue for the quarter came in at $12.8 million versus the consensus estimate of $8.66 million.

GUIDANCE:

Exagen Inc. sees Q1 2023 revenue of $9.2-9.7 million, versus the consensus... More